SEMI Country excerpt 4: China, BYD, and the battle for EV supremacy
China’s EV industry is now building on the past glories of its automotive sector. The much-criticized issue of “overcapacity” seems…
Color e-paper industry sees growth with large displays and new tech
The electronic paper (e-paper) industry is thriving with innovations in color technology. E Ink Holdings (EIH) and Netronix experienced a…
Global fab equipment spending to surge 18% in 2026, says SEMI
Global investment in front-end fab equipment is projected to increase by 2% year over year to US$110 billion in 2025,…
Taiwan’s new IDA director to focus on industrial transformation, economic resilience
Taiwan’s Ministry of Economic Affairs (MOEA) promoted Chyou-Huey Chiou to director general of the Industrial Development Administration (IDA) on March…
Trump’s energy policy shifts affect growth in US renewable energy sector; Texas faces potential setbacks
The Trump administration is disrupting US energy policies with executive orders that roll back clean energy initiatives and emphasize fossil…
Tariff risk could reshape Taiwan’s server production dynamics in Mexico, Southeast Asia, says DIGITIMES
Amid uncertainties regarding US tariff policy, Taiwanese server manufacturers are adapting for the future. DIGITIMES analyst Yen Chou noted that…
OpenAI, Google, and Anthropic unveil competing proposals to shape Trump’s AI Action Plan
With the White House soliciting industry input for its “Artificial Intelligence Action Plan” until March 15, OpenAI, Google, and Anthropic…
FDA approves durvalumab for muscle invasive bladder cancer
On March 28, 2025, the Food and Drug Administration approved durvalumab (Imfinzi, AstraZeneca) with gemcitabine and cisplatin as neoadjuvant treatment,…
FDA Approves Novel Treatment for Hemophilia A or B, with or without Factor Inhibitors
Today, the U.S. Food and Drug Administration approved a novel treatment for hemophilia A or B, with or without factor…
Scientific Public Private Partnerships and Consortia
Find out how CDER works with partners and consortia to identify science gaps in drug development